SABA Reliance Questionnaire (SRQ): Identifying Patient Beliefs Underpinning Reliever Overreliance in Asthma

Chan, Amy Hai Yan; Katzer, Caroline Brigitte; Horne, Rob; Haughney, John; Sousa, Jaime Correia de; Williams, Siân; Kaplan, Alan

doi:10.1016/j.jaip.2020.07.014

Cited by 18 publications

(18 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The importance of understanding patterns of SABA use is reflected in the current asthma guidelines [ 59 , 60 ] and PROs such as the ACT [ 61 ] and SABA Reliance Questionnaire (SRQ) [ 62 ]. These include measures of SABA frequency to judge disease control and/or severity, and risk of over-reliance on SABA.…”

Section: Methodsmentioning

confidence: 99%

“…These include measures of SABA frequency to judge disease control and/or severity, and risk of over-reliance on SABA. The SRQ assesses patient perceptions of SABA and identifies key beliefs that may be driving SABA overuse [ 62 ]. The frequency of β-2 agonist use is commonly used by clinicians during encounters, and assessment of SABA use is now recommended in current guidelines as a measure of disease control for asthma or COPD, as overuse of SABA is related to increased morbidity and mortality [ 56 ].…”

Section: Methodsmentioning

confidence: 99%

See 1 more Smart Citation

Digital Inhalers for Asthma or Chronic Obstructive Pulmonary Disease: A Scientific Perspective

et al. 2021

View full text Add to dashboard Cite

Impressive advances in inhalation therapy for patients with asthma and chronic obstructive pulmonary disease (COPD) have occurred in recent years. However, important gaps in care remain, particularly relating to poor adherence to inhaled therapies. Digital inhaler health platforms which incorporate digital inhalers to monitor time and date of dosing are an effective disease and medication management tool, promoting collaborative care between clinicians and patients, and providing more in-depth understanding of actual inhaler use. With advances in technology, nearly all inhalers can be digitalized with add-on or embedded sensors to record and transmit data quantitating inhaler actuations, and some have additional capabilities to evaluate inhaler technique. In addition to providing an objective and readily available measure of adherence, they allow patients to interact with the device directly or through their self-management smartphone application such as via alerts and recording of health status. Clinicians can access these data remotely and

show abstract

Section: Methodsmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

Digital Inhalers for Asthma or Chronic Obstructive Pulmonary Disease: A Scientific Perspective

et al. 2021

View full text Add to dashboard Cite

show abstract

“…The use of upcoming tools such as the SABA Reliance Questionnaire may help physicians to assess patients’ beliefs about SABA. [ 81 ] It can also initiate a dialogue between patients and providers and may alleviate SABA monotherapy and overuse.…”

Section: Short-acting β-Agonists Alone-free Clinical Practicementioning

confidence: 99%

Challenges and recommendations for the management of asthma in the Middle East and Africa

Zeitouni

Al-Moamary

Coussa

et al. 2022

Annals of Thoracic Medicine

View full text Add to dashboard Cite

Clinical presentation of asthma is variable, and its diagnosis can be a major challenge in routine health-care practice, especially in low-and-middle-income countries. The aim of asthma management is to achieve optimal asthma control and to reduce the risk of asthma exacerbations and mortality. In the Middle East and in Africa (MEA), several patient- and physician-related factors lead to misdiagnosis and suboptimal management of asthma. A panel of experts comprising of specialists as well as general health-care professionals met to identify challenges and provide recommendations for the management of asthma in MEA. The major challenges identified for diagnosis of asthma were lack of adequate knowledge about the disease, lack of specialized diagnostic facilities, limited access to spirometry, and social stigma associated with asthma. The prime challenges for management of asthma in MEA were identified as overreliance on short-acting β-agonists (SABAs), underprescription of inhaled corticosteroids (ICS), nonadherence to prescribed medications, and inadequate insurance coverage for its treatment. The experts endorsed adapting the Global Initiative for Asthma guidelines at country and regional levels for effective management of asthma and to alleviate the overuse of SABAs as reliever medications. Stringent control over SABA use, discouraging over-the-counter availability of SABA, and using as-needed low-dose ICS and formoterol as rescue medications in mild cases were suggested to reduce the overreliance on SABAs. Encouraging SABA alone-free clinical practice in both outpatient and emergency department settings is also imperative. We present the recommendations for the management of asthma along with proposed regional adaptations of international guidelines for MEA.

show abstract

“…The SRQ assesses patient beliefs about SABA to identify patients at risk of SABA over-reliance and overuse. (12).…”

Section: Mars For Ics (If Applicable)mentioning

confidence: 99%

“…The Risk of Reliance Test (RRT) is a recently developed, brief, online intervention for patients with asthma, to identify and change patient beliefs driving inappropriate SABA use. (12) The RRT comprises two parts: the SABA Reliance Questionnaire (SRQ) along with personalised behaviour change messages based on participant responses to the SRQ. The SRQ is a validated questionnaire that identi es patient beliefs in uencing SABA over-reliance and overuse.…”

Section: Introductionmentioning

confidence: 99%

Study protocol for a feasibility trial in community pharmacy of a personalised behaviour change intervention to reduce reliever reliance and overuse in individuals with asthma.

Foot

Beyene

Horne

et al. 2021

Preprint

Self Cite

View full text Add to dashboard Cite

BackgroundIn patients with asthma, over-reliance and overuse of short-acting beta2 agonist (SABA) is common and associated with increased morbidity and mortality. Patient beliefs are a key driver of inappropriate reliever use. A recently developed, brief, online intervention has been shown to identify and shift patient beliefs that drive inappropriate reliever use. Whether this intervention works to shift beliefs in individuals with asthma when delivered by community pharmacists is unknown. ObjectiveTo investigate the feasibility and acceptability of a brief community pharmacist-delivered behavior change intervention, and its effect on beliefs about SABA and SABA use in patients with asthma. MethodsThis is a non-randomised, before- and after- study of 120 individuals aged 18 years and older, prescribed a SABA for their asthma symptoms, presenting to one of two enrolled community pharmacies in Auckland, New Zealand. At enrolment, all participants will complete the SABA Reliance Questionnaire (SRQ), Asthma Control Test and 5-item Medication Adherence Report Scale via an online survey platform. Control participants will receive usual asthma care from their community pharmacy. Intervention participants will receive the intervention to shift any misplaced beliefs about SABA, comprising the SRQ to identify individual beliefs about SABA, then personalized information and discussion between pharmacist and patient based on the specific responses to the questionnaires. Those on SABA monotherapy and/or are at risk of SABA overuse will be referred to the general practitioner. Effect on beliefs about SABA and actual SABA use will be assessed by the SRQ and dispensing records, respectively. Feasibility will be evaluated through participant recruitment and retention rates, intervention fidelity, appropriateness and procedures of outcome measures pre- and post-intervention, and acceptability by obtaining feedback from participants (both patients and pharmacists) on the intervention.

show abstract

SABA Reliance Questionnaire (SRQ): Identifying Patient Beliefs Underpinning Reliever Overreliance in Asthma

Cited by 18 publications

References 28 publications

Digital Inhalers for Asthma or Chronic Obstructive Pulmonary Disease: A Scientific Perspective

Digital Inhalers for Asthma or Chronic Obstructive Pulmonary Disease: A Scientific Perspective

Challenges and recommendations for the management of asthma in the Middle East and Africa

Study protocol for a feasibility trial in community pharmacy of a personalised behaviour change intervention to reduce reliever reliance and overuse in individuals with asthma.

Contact Info

Product

Resources

About